Danielle Rodin

3.8k total citations · 1 hit paper
109 papers, 1.9k citations indexed

About

Danielle Rodin is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Danielle Rodin has authored 109 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 44 papers in Radiology, Nuclear Medicine and Imaging and 33 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Danielle Rodin's work include Advances in Oncology and Radiotherapy (38 papers), Advanced Radiotherapy Techniques (24 papers) and Global Cancer Incidence and Screening (18 papers). Danielle Rodin is often cited by papers focused on Advances in Oncology and Radiotherapy (38 papers), Advanced Radiotherapy Techniques (24 papers) and Global Cancer Incidence and Screening (18 papers). Danielle Rodin collaborates with scholars based in Canada, United States and Australia. Danielle Rodin's co-authors include Yolande Lievens, Mary Gospodarowicz, Felícia Marie Knaul, Eduardo Zubizarreta, Rifat Atun, David A. Jaffray, Timothy P. Hanna, Surbhi Grover, Michael Milosevic and Brian O’Sullivan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Danielle Rodin

95 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expanding global access to radiotherapy

2015 683 citations Yolande Lievens, Danielle Rodin et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danielle Rodin Canada	20	867	619	496	413	311	109	1.9k
Trevor J. Royce United States	25	481 0.6×	269 0.4×	708 1.4×	695 1.7×	356 1.1×	134	2.1k
Shalini Vinod Australia	30	1.4k 1.6×	1.0k 1.7×	787 1.6×	1.4k 3.5×	265 0.9×	162	3.1k
Curtiland Deville United States	30	1.1k 1.3×	593 1.0×	443 0.9×	1.0k 2.5×	692 2.2×	168	2.9k
Emma B. Holliday United States	30	726 0.8×	467 0.8×	667 1.3×	845 2.0×	765 2.5×	163	3.0k
Suzanne B. Evans United States	24	430 0.5×	446 0.7×	495 1.0×	228 0.6×	163 0.5×	92	1.8k
Daniel W. Golden United States	23	587 0.7×	362 0.6×	392 0.8×	424 1.0×	257 0.8×	145	2.0k
Ewa Szumacher Canada	26	323 0.4×	496 0.8×	424 0.9×	1.0k 2.5×	330 1.1×	92	2.0k
Timothy P. Hanna Canada	23	1.2k 1.3×	807 1.3×	1.6k 3.2×	816 2.0×	387 1.2×	119	3.6k
Charles Hayter Canada	24	325 0.4×	505 0.8×	509 1.0×	932 2.3×	323 1.0×	56	2.0k
Neha Vapiwala United States	31	908 1.0×	822 1.3×	947 1.9×	1.6k 3.8×	444 1.4×	257	3.7k

Countries citing papers authored by Danielle Rodin

Since Specialization

Citations

This map shows the geographic impact of Danielle Rodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Rodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Rodin more than expected).

Fields of papers citing papers by Danielle Rodin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Rodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Rodin. The network helps show where Danielle Rodin may publish in the future.

Co-authorship network of co-authors of Danielle Rodin

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Rodin. A scholar is included among the top collaborators of Danielle Rodin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Rodin. Danielle Rodin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gong, Inna Y., Mark J. Soto, Joseph M. Unger, et al.. (2025). Disparities in clinical trial participation among older adult Medicare beneficiaries with hematologic malignancies from 2006 to 2019: A SEER–Medicare analysis. Cancer. 131(24). e70204–e70204.

Gong, Inna Y., Michael Crump, Anca Prica, et al.. (2025). Outcomes and factors influencing survival in patients with diffuse large B-cell lymphoma: a population-based analysis. PubMed. 2(3). 100117–100117.

Wong, Geoff, Alejandro Berlín, Julie Easley, et al.. (2025). Optimizing Virtual Follow-Up Care: Realist Evaluation of Experiences and Perspectives of Patients With Breast and Prostate Cancer. Journal of Medical Internet Research. 27. e65148–e65148. 1 indexed citations

Rodin, Danielle, et al.. (2025). Cancer models in nanomedicine research: Rethinking in vitro models for translational nanomedicine. Nano Today. 66. 102911–102911.

Gong, Inna Y., Meredith B. Rosenthal, Mark J. Soto, et al.. (2024). Disparities in Clinical Trial Participation Among Medicare Beneficiaries with Hematologic Malignancies from 2006 to 2019: A SEER-Medicare Analysis. Blood. 144(Supplement 1). 5113–5113. 1 indexed citations

Gong, Inna Y., Haris Majeed, Mark J. Soto, et al.. (2024). Disparities in Phase II and III Clinical Trial Enrollment for Hematologic Malignancies. Blood. 144(Supplement 1). 5100–5100.

Hahn, Ezra, Rinku Sutradhar, Danielle Rodin, et al.. (2024). Molecular Expression Assays Improve the Prediction of Local and Invasive Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ. Journal of Clinical Oncology. 42(27). 3196–3206. 2 indexed citations

Bender, Jacqueline L., Geoff Wong, Nazek Abdelmutti, et al.. (2024). Virtual follow‐up care among breast and prostate cancer patients during and beyond the COVID‐19 pandemic: Association with distress. Cancer Medicine. 13(4). e6948–e6948. 3 indexed citations

Gong, Inna Y., Michael Crump, Anca Prica, et al.. (2024). Outcomes and Predictors of Survival for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Large Population-Based Analysis. Blood. 144(Supplement 1). 3092–3092.

10.

Yap, Mei Ling & Danielle Rodin. (2024). Radiotherapy gaps and new frontiers in the Commonwealth. The Lancet Oncology. 25(11). 1394–1396. 1 indexed citations

11.

Hahn, Ezra, Danielle Rodin, Rinku Sutradhar, et al.. (2023). Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?. Current Oncology. 30(6). 5795–5806. 5 indexed citations

12.

Silverstein, Allison, Pascale Yola Gassant, Sanjeeva Gunasekera, et al.. (2023). Factors influencing treatment decision‐making for cancer patients in low‐ and middle‐income countries: A scoping review. Cancer Medicine. 12(17). 18133–18152. 9 indexed citations

13.

Weiss, Jessica, Bouchra Tawk, Fábio Ynoe de Moraes, et al.. (2023). Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey. JCO Global Oncology. 9(9). e2300046–e2300046. 4 indexed citations

14.

Vijenthira, Abi, et al.. (2023). Virtual Care During the COVID-19 Pandemic for Patients With Hematologic Malignancies: A Single-Institution Experience. JCO Oncology Practice. 19(5). e672–e682. 1 indexed citations

15.

Weiss, Jessica, Zhihui Amy Liu, Anna Mary Nyakabau, et al.. (2023). Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey. JCO Global Oncology. 9(9). e2200127–e2200127. 9 indexed citations

16.

Wilson, Brooke E., Rouhi Fazelzad, Aliyah Pabani, et al.. (2023). Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes. BMJ Open. 13(2). e068122–e068122. 14 indexed citations

17.

Liu, Zhihui Amy, et al.. (2022). Virtual Care and Electronic Patient Communication During COVID-19: Cross-sectional Study of Inequities Across a Canadian Tertiary Cancer Center. Journal of Medical Internet Research. 24(11). e39728–e39728. 8 indexed citations

18.

Rodin, Danielle, Bouchra Tawk, Osama Mohamad, et al.. (2021). Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey. Radiotherapy and Oncology. 157. 32–39. 53 indexed citations

19.

Khader, Jamal, Rachel Glicksman, Asem Mansour, et al.. (2020). Enhancing International Cancer Organization Collaborations: King Hussein Cancer Center and Princess Margaret Cancer Centre Model for Collaboration. Journal of Cancer Education. 37(3). 763–769. 2 indexed citations

20.

Grover, Surbhi, Melody Xu, Alyssa Yeager, et al.. (2015). A Systematic Review of Radiotherapy Capacity in Low- and Middle-Income Countries. Frontiers in Oncology. 4. 380–380. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact